MSC therapy for respiratory distress syndrome
Design, validate or accelerate clinical development with expert infrastructures.
Offer overview
What this offer helps you achieve
Design, validate or accelerate clinical development with expert infrastructures.
Scientific and technical scope
Preventing serious adverse events of acute respiratory distress syndrome with MSCs developed by Antoine Monsel Phase : Phase IIb clinical trial Umbilical cord-derived mesenchymal stromal cell therapy in SARS-CoV-2-associated acute respiratory distress syndrome (ARDS) clinical trials - NCT04333368 Sitbon et al. Stem Cell Res Ther. 2024 Apr 19;15(1):109. doi: 10.1186/s13287-024-03729-w
Capabilities mobilised
Therapeutic areasExpert adviceTherapeutic target discoveryClinical validation
Application fields
Respiratory distress
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
